Logo image of HAO

HAOXI HEALTH TECHNOLOGY LTD (HAO) Stock Fundamental Analysis

NASDAQ:HAO - Nasdaq - KYG4290F1182 - Common Stock - Currency: USD

1.59  +0.14 (+9.66%)

After market: 1.41 -0.18 (-11.32%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to HAO. HAO was compared to 96 industry peers in the Media industry. HAO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. HAO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

HAO had positive earnings in the past year.
In the past year HAO has reported a negative cash flow from operations.
HAO Yearly Net Income VS EBIT VS OCF VS FCFHAO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M 2M

1.2 Ratios

HAO has a Return On Assets of 13.23%. This is amongst the best in the industry. HAO outperforms 95.83% of its industry peers.
HAO has a Return On Equity of 18.20%. This is amongst the best in the industry. HAO outperforms 90.63% of its industry peers.
HAO has a Return On Invested Capital of 15.84%. This is amongst the best in the industry. HAO outperforms 97.92% of its industry peers.
Industry RankSector Rank
ROA 13.23%
ROE 18.2%
ROIC 15.84%
ROA(3y)25.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HAO Yearly ROA, ROE, ROICHAO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

Looking at the Profit Margin, with a value of 2.85%, HAO is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
HAO's Profit Margin has improved in the last couple of years.
HAO's Operating Margin of 3.52% is in line compared to the rest of the industry. HAO outperforms 48.96% of its industry peers.
HAO's Operating Margin has improved in the last couple of years.
The Gross Margin of HAO (5.49%) is worse than 82.29% of its industry peers.
HAO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.52%
PM (TTM) 2.85%
GM 5.49%
OM growth 3Y11.17%
OM growth 5YN/A
PM growth 3Y4.01%
PM growth 5YN/A
GM growth 3Y6.32%
GM growth 5YN/A
HAO Yearly Profit, Operating, Gross MarginsHAO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2 4 6

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HAO is creating value.
HAO has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, HAO has an improved debt to assets ratio.
HAO Yearly Shares OutstandingHAO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
HAO Yearly Total Debt VS Total AssetsHAO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

HAO has an Altman-Z score of 6.72. This indicates that HAO is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.72, HAO belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that HAO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.10, HAO is in the better half of the industry, outperforming 78.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 6.72
ROIC/WACC2.34
WACC6.76%
HAO Yearly LT Debt VS Equity VS FCFHAO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

A Current Ratio of 3.98 indicates that HAO has no problem at all paying its short term obligations.
HAO has a better Current ratio (3.98) than 93.75% of its industry peers.
HAO has a Quick Ratio of 3.98. This indicates that HAO is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.98, HAO belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.98
Quick Ratio 3.98
HAO Yearly Current Assets VS Current LiabilitesHAO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 53.15% over the past year.
The Earnings Per Share has been growing by 61.60% on average over the past years. This is a very strong growth
HAO shows a strong growth in Revenue. In the last year, the Revenue has grown by 92.62%.
The Revenue has been growing by 55.73% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)53.15%
EPS 3Y61.6%
EPS 5YN/A
EPS Q2Q%38.82%
Revenue 1Y (TTM)92.62%
Revenue growth 3Y55.73%
Revenue growth 5YN/A
Sales Q2Q%71.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HAO Yearly Revenue VS EstimatesHAO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.71, HAO is valued on the expensive side.
Based on the Price/Earnings ratio, HAO is valued a bit cheaper than the industry average as 65.63% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 25.82. HAO is around the same levels.
Industry RankSector Rank
PE 22.71
Fwd PE N/A
HAO Price Earnings VS Forward Price EarningsHAO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -1.1
HAO Per share dataHAO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

HAO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HAOXI HEALTH TECHNOLOGY LTD

NASDAQ:HAO (5/23/2025, 8:20:55 PM)

After market: 1.41 -0.18 (-11.32%)

1.59

+0.14 (+9.66%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.99%
Inst Owner Change-98.2%
Ins Owners21.79%
Ins Owner ChangeN/A
Market Cap4.48M
Analysts0
Price TargetN/A
Short Float %3.14%
Short Ratio1.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.71
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B 0.4
P/tB 0.4
EV/EBITDA -1.1
EPS(TTM)0.07
EY4.4%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS25.54
BVpS4
TBVpS4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.23%
ROE 18.2%
ROCE 21.78%
ROIC 15.84%
ROICexc 35.58%
ROICexgc 35.58%
OM 3.52%
PM (TTM) 2.85%
GM 5.49%
FCFM N/A
ROA(3y)25.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.92%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y11.17%
OM growth 5YN/A
PM growth 3Y4.01%
PM growth 5YN/A
GM growth 3Y6.32%
GM growth 5YN/A
F-Score3
Asset Turnover4.64
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 0.45
Cap/Depr 522.64%
Cap/Sales 0.08%
Interest Coverage 67.98
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.98
Quick Ratio 3.98
Altman-Z 6.72
F-Score3
WACC6.76%
ROIC/WACC2.34
Cap/Depr(3y)486.59%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.11%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.15%
EPS 3Y61.6%
EPS 5YN/A
EPS Q2Q%38.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)92.62%
Revenue growth 3Y55.73%
Revenue growth 5YN/A
Sales Q2Q%71.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y50.17%
EBIT growth 3Y73.12%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.28%
OCF growth 3YN/A
OCF growth 5YN/A